Cargando…
Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting 1% of the world population. RA is associated with the presence of autoantibodies, of which anti-citrullinated protein antibodies (ACPA) are most prominent. ACPA are produced by citrullinated antigen-binding B cells that have presuma...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009422/ https://www.ncbi.nlm.nih.gov/pubmed/33784344 http://dx.doi.org/10.1371/journal.pone.0247847 |
_version_ | 1783672872731934720 |
---|---|
author | Slot, Linda M. Vergroesen, Rochelle D. Kerkman, Priscilla F. Staudinger, Ellen Reijm, Sanne van Dooren, Hugo J. van der Voort, Ellen I. H. Huizinga, Tom W. J. Toes, René E. M. Scherer, Hans U. |
author_facet | Slot, Linda M. Vergroesen, Rochelle D. Kerkman, Priscilla F. Staudinger, Ellen Reijm, Sanne van Dooren, Hugo J. van der Voort, Ellen I. H. Huizinga, Tom W. J. Toes, René E. M. Scherer, Hans U. |
author_sort | Slot, Linda M. |
collection | PubMed |
description | Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting 1% of the world population. RA is associated with the presence of autoantibodies, of which anti-citrullinated protein antibodies (ACPA) are most prominent. ACPA are produced by citrullinated antigen-binding B cells that have presumably survived tolerance checkpoints. So far, it is unclear how and when such autoreactive B cells emerge. Light chain (LC) rearrangement and mutation rates can be informative with regard to selection steps during B-cell development. Therefore, we studied LC characteristics of ACPA-expressing B cells and secreted ACPA with the aim to better understand the development of this disease-specific, autoreactive B-cell response. Paired ACPA-IgG and ACPA-depleted IgG were isolated from serum (n = 87) and synovial fluid (SF, n = 21) of patients with established RA. We determined the LC composition for each fraction by ELISA using kappa(Igκ)- and lambda(Igλ) LC-specific antibodies. Cellular LC expression was determined using flow cytometry. In addition, we used a B-cell receptor (BCR)-specific PCR to obtain LC variable region sequences of citrullinated antigen- and tetanus toxoid (TT)-binding B cells. In serum, we observed an increased frequency of lambda LC in ACPA-IgG (1.64:1) compared to control IgG (2.03:1) and to the κ/λ ratio reported for healthy individuals (2:1). A similar trend towards higher frequencies of lambda LCs was observed for ACPA-IgG in SF (1.84:1). Additionally, the percentage of Igλ-expressing B cells was higher for citrullinated antigen-binding B cells (51%) compared to TT-specific (43%) and total CD19(+)CD20(+) B cells (36%). Moreover, an increased Igλ percentage was observed in BCR-sequences derived from ACPA-expressing (49%) compared to TT-specific B cells (34%). Taken together, we report an enhanced frequency of lambda LCs in the secreted ACPA-IgG repertoire and, on the cellular level, in BCR sequences of ACPA-expressing B cells compared to control. This skewing in the autoreactive B-cell repertoire could reflect a process of active selection. |
format | Online Article Text |
id | pubmed-8009422 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-80094222021-04-07 Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis Slot, Linda M. Vergroesen, Rochelle D. Kerkman, Priscilla F. Staudinger, Ellen Reijm, Sanne van Dooren, Hugo J. van der Voort, Ellen I. H. Huizinga, Tom W. J. Toes, René E. M. Scherer, Hans U. PLoS One Research Article Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting 1% of the world population. RA is associated with the presence of autoantibodies, of which anti-citrullinated protein antibodies (ACPA) are most prominent. ACPA are produced by citrullinated antigen-binding B cells that have presumably survived tolerance checkpoints. So far, it is unclear how and when such autoreactive B cells emerge. Light chain (LC) rearrangement and mutation rates can be informative with regard to selection steps during B-cell development. Therefore, we studied LC characteristics of ACPA-expressing B cells and secreted ACPA with the aim to better understand the development of this disease-specific, autoreactive B-cell response. Paired ACPA-IgG and ACPA-depleted IgG were isolated from serum (n = 87) and synovial fluid (SF, n = 21) of patients with established RA. We determined the LC composition for each fraction by ELISA using kappa(Igκ)- and lambda(Igλ) LC-specific antibodies. Cellular LC expression was determined using flow cytometry. In addition, we used a B-cell receptor (BCR)-specific PCR to obtain LC variable region sequences of citrullinated antigen- and tetanus toxoid (TT)-binding B cells. In serum, we observed an increased frequency of lambda LC in ACPA-IgG (1.64:1) compared to control IgG (2.03:1) and to the κ/λ ratio reported for healthy individuals (2:1). A similar trend towards higher frequencies of lambda LCs was observed for ACPA-IgG in SF (1.84:1). Additionally, the percentage of Igλ-expressing B cells was higher for citrullinated antigen-binding B cells (51%) compared to TT-specific (43%) and total CD19(+)CD20(+) B cells (36%). Moreover, an increased Igλ percentage was observed in BCR-sequences derived from ACPA-expressing (49%) compared to TT-specific B cells (34%). Taken together, we report an enhanced frequency of lambda LCs in the secreted ACPA-IgG repertoire and, on the cellular level, in BCR sequences of ACPA-expressing B cells compared to control. This skewing in the autoreactive B-cell repertoire could reflect a process of active selection. Public Library of Science 2021-03-30 /pmc/articles/PMC8009422/ /pubmed/33784344 http://dx.doi.org/10.1371/journal.pone.0247847 Text en © 2021 Slot et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Slot, Linda M. Vergroesen, Rochelle D. Kerkman, Priscilla F. Staudinger, Ellen Reijm, Sanne van Dooren, Hugo J. van der Voort, Ellen I. H. Huizinga, Tom W. J. Toes, René E. M. Scherer, Hans U. Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis |
title | Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis |
title_full | Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis |
title_fullStr | Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis |
title_full_unstemmed | Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis |
title_short | Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis |
title_sort | light chain skewing in autoantibodies and b-cell receptors of the citrullinated antigen-binding b-cell response in rheumatoid arthritis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009422/ https://www.ncbi.nlm.nih.gov/pubmed/33784344 http://dx.doi.org/10.1371/journal.pone.0247847 |
work_keys_str_mv | AT slotlindam lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis AT vergroesenrochelled lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis AT kerkmanpriscillaf lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis AT staudingerellen lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis AT reijmsanne lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis AT vandoorenhugoj lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis AT vandervoortellenih lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis AT huizingatomwj lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis AT toesreneem lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis AT schererhansu lightchainskewinginautoantibodiesandbcellreceptorsofthecitrullinatedantigenbindingbcellresponseinrheumatoidarthritis |